메뉴 건너뛰기




Volumn 9, Issue 3, 2010, Pages 263-270

Dose escalation study with two different hypofractionated intensity modulated radiotherapy techniques for localized prostate cancer: Acute toxicity

Author keywords

Acute toxicity; Dose escalation; Hypofractionation; IMRT; Prostate cancer

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BICALUTAMIDE; GOSERELIN; LEUPRORELIN; NONSTEROID ANTIINFLAMMATORY AGENT;

EID: 77953240192     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303461000900305     Document Type: Article
Times cited : (3)

References (28)
  • 3
    • 14544289582 scopus 로고    scopus 로고
    • Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate
    • DOI 10.1200/JCO.2005.06.154
    • Sathya, J. R., Davis, I. R., Julian, J. A., Guo, Q., Daya, D., Dayes, I. S., Lukka, H. R., Levine, M. Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. J Clin Oncol 23, 1192-1199 (2005). (Pubitemid 46202276)
    • (2005) Journal of Clinical Oncology , vol.23 , Issue.6 , pp. 1192-1199
    • Sathya, J.R.1    Davis, I.R.2    Julian, J.A.3    Guo, Q.4    Daya, D.5    Dayes, I.S.6    Lukka, H.R.7    Levine, M.8
  • 4
    • 24644443217 scopus 로고    scopus 로고
    • Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial
    • Zietman, A. L., DeSilvio, M. L., Slater, J. D., Rossi, C. J., Jr., Miller, D. W., Adams, J. A., Shipley, W. U. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294, 1233-1239 (2005).
    • (2005) JAMA , vol.294 , pp. 1233-1239
    • Zietman, A.L.1    DeSilvio, M.L.2    Slater, J.D.3    Rossi Jr., C.J.4    Miller, D.W.5    Adams, J.A.6    Shipley, W.U.7
  • 5
    • 30344480257 scopus 로고    scopus 로고
    • Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: Analysis of acute toxicity
    • DOI 10.1016/j.urology.2005.07.021, PII S009042950501112X
    • Jani, A. B., Su, A., Milano, M. T. Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: analysis of acute toxicity. Urology 67, 147-151 (2006). (Pubitemid 43069274)
    • (2006) Urology , vol.67 , Issue.1 , pp. 147-151
    • Jani, A.B.1    Su, A.2    Milano, M.T.3
  • 7
    • 0032913909 scopus 로고    scopus 로고
    • Fractionation and protraction for radiotherapy of prostate carcinoma
    • Brenner, D. J., Hall, E. J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43, 1095-1101 (1999).
    • (1999) Int J Radiat Oncol Biol Phys , vol.43 , pp. 1095-1101
    • Brenner, D.J.1    Hall, E.J.2
  • 8
    • 0036140325 scopus 로고    scopus 로고
    • Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue
    • DOI 10.1016/S0360-3016(01)02664-5, PII S0360301601026645
    • Brenner, D. J., Martinez, A. A., Edmundson, G. K., Mitchell, C., Thames, H. D., Armour, E. P. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 52, 6-13 (2002). (Pubitemid 34041562)
    • (2002) International Journal of Radiation Oncology Biology Physics , vol.52 , Issue.1 , pp. 6-13
    • Brenner, D.J.1    Martinez, A.A.2    Edmundson, G.K.3    Mitchell, C.4    Thames, H.D.5    Armour, E.P.6
  • 14
    • 0035889347 scopus 로고    scopus 로고
    • Short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Preliminary results on late toxicity and quality of life
    • Kupelian, P. A., Reddy, C. A., Klein, E. A., Willoughby, T. R. Short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life. Int J Radiat Oncol Biol Phys 51, 988-993 (2001).
    • (2001) Int J Radiat Oncol Biol Phys , vol.51 , pp. 988-993
    • Kupelian, P.A.1    Reddy, C.A.2    Klein, E.A.3    Willoughby, T.R.4
  • 15
    • 34547431049 scopus 로고    scopus 로고
    • Hypofractionated Intensity-Modulated Radiotherapy (70 Gy at 2.5 Gy Per Fraction) for Localized Prostate Cancer: Cleveland Clinic Experience
    • DOI 10.1016/j.ijrobp.2007.01.067, PII S0360301607005354
    • Kupelian, P. A., Willoughby, T. R., Reddy, C. A., Klein, E. A., Mahadevan, A. Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience. Int J Radiat Oncol Biol Phys 68, 1424-1430 (2007). (Pubitemid 47176809)
    • (2007) International Journal of Radiation Oncology Biology Physics , vol.68 , Issue.5 , pp. 1424-1430
    • Kupelian, P.A.1    Willoughby, T.R.2    Reddy, C.A.3    Klein, E.A.4    Mahadevan, A.5
  • 16
    • 33746994052 scopus 로고    scopus 로고
    • Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: Report on acute toxicity
    • DOI 10.1016/j.radonc.2006.06.005, PII S0167814006002477
    • Soete, G., Arcangeli, S., De Meerleer, G., Landoni, V., Fonteyne, V., Arcangeli, G., De Neve, W., Storme, G. Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: report on acute toxicity. Radiother Oncol 80, 78-81 (2006). (Pubitemid 44205307)
    • (2006) Radiotherapy and Oncology , vol.80 , Issue.1 , pp. 78-81
    • Soete, G.1    Arcangeli, S.2    De Meerleer, G.3    Landoni, V.4    Fonteyne, V.5    Arcangeli, G.6    De Neve, W.7    Storme, G.8
  • 17
    • 52649083527 scopus 로고    scopus 로고
    • Acute toxicity after hypofractionated conformal radiotherapy for localized prostate cancer: Nonrandomized contemporary comparison with standard fractionation
    • Leborgne, F., Fowler, J. Acute toxicity after hypofractionated conformal radiotherapy for localized prostate cancer: nonrandomized contemporary comparison with standard fractionation. Int J Radiat Oncol Biol Phys 72, 770-776 (2008).
    • (2008) Int J Radiat Oncol Biol Phys , vol.72 , pp. 770-776
    • Leborgne, F.1    Fowler, J.2
  • 18
    • 33847248003 scopus 로고    scopus 로고
    • Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: First clinical trial results
    • DOI 10.1016/j.ijrobp.2006.10.050, PII S0360301606033694
    • Madsen, B. L., Hsi, R. A., Pham, H. T., Fowler, J. F., Esagui, L., Corman, J. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. Int J Radiat Oncol Biol Phys 67, 1099-1105 (2007). (Pubitemid 46320084)
    • (2007) International Journal of Radiation Oncology Biology Physics , vol.67 , Issue.4 , pp. 1099-1105
    • Madsen, B.L.1    Hsi, R.A.2    Pham, H.T.3    Fowler, J.F.4    Esagui, L.5    Corman, J.6
  • 22
    • 0027938462 scopus 로고
    • Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer
    • Diaz, A., Roach, M., 3rd, Marquez, C., Coleman, L., Pickett, B., Wolfe, J. S., Carroll, P., Narayan, P. Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 30, 323-329 (1994).
    • (1994) Int J Radiat Oncol Biol Phys , vol.30 , pp. 323-329
    • Diaz, A.1    Roach III, M.2    Marquez, C.3    Coleman, L.4    Pickett, B.5    Wolfe, J.S.6    Carroll, P.7    Narayan, P.8
  • 24
    • 0028969271 scopus 로고
    • Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
    • Cox, J. D., Stetz, J., Pajak, T. F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31, 1341-1346 (1995).
    • (1995) Int J Radiat Oncol Biol Phys , vol.31 , pp. 1341-1346
    • Cox, J.D.1    Stetz, J.2    Pajak, T.F.3
  • 25
    • 0345304221 scopus 로고    scopus 로고
    • Acute radiation reactions in oral and pharyngeal mucosa: Tolerable levels in altered fractionation schedules
    • Fowler, J. F., Harari, P. M., Leborgne, F., Leborgne, J. H. Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules. Radiother Oncol 69, 161-168 (2003).
    • (2003) Radiother Oncol , vol.69 , pp. 161-168
    • Fowler, J.F.1    Harari, P.M.2    Leborgne, F.3    Leborgne, J.H.4
  • 26
    • 0028085354 scopus 로고
    • Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy
    • Zelefsky, M. J., Leibel, S. A., Burman, C. M., Kutcher, G. J., Harrison, A., Happersett, L., Fuks, Z. Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 29, 755-761 (1994).
    • (1994) Int J Radiat Oncol Biol Phys , vol.29 , pp. 755-761
    • Zelefsky, M.J.1    Leibel, S.A.2    Burman, C.M.3    Kutcher, G.J.4    Harrison, A.5    Happersett, L.6    Fuks, Z.7
  • 28
    • 0141615701 scopus 로고    scopus 로고
    • RTOG 94-06: Is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity?
    • Valicenti, R. K., Winter, K., Cox, J. D., Sandler, H. M., Bosch, W., Vijayakumar, S., Michalski, J., Purdy, J. RTOG 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity? Int J Radiat Oncol Biol Phys 57, 614-620 (2003).
    • (2003) Int J Radiat Oncol Biol Phys , vol.57 , pp. 614-620
    • Valicenti, R.K.1    Winter, K.2    Cox, J.D.3    Sandler, H.M.4    Bosch, W.5    Vijayakumar, S.6    Michalski, J.7    Purdy, J.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.